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INTRODUCTION.
When  in  the  course  of  our  studies on  Bacterium pneumosintes it
was  found  that  experimental  infection  protected  rabbits  against
subsequent  intratracheal  inoculations  of  living organisms,'  and that
intravenous  doses  of  living  or  dead  bacteria  stimulated  specific
antibody formation,2 we were led to investigate the protective efficacy
of small  subcutaneous  injections  of  the heat-killed  organisms.  The
results of these  experiments have already  been reported in Paper XS
of  this series.  They may  be reviewed  briefly  as  an introduction  to
the  somewhat  similar  study  in man  which  forms  the  basis  of  this
article.
Three  measured  doses  of heat-killed  Bacterium pneumosintes, injected  sub-
cutaneously  in rabbits  at suitable  intervals,  induced  an appreciable  specific  ag-
glutinin formation  in all but a few of the animals.  The vaccinated rabbits were
then found  to be  resistant to  intratracheal  injections  of living B. pneumosintes,
obtained  from  cultures  or contained  in  the  lung  tissues  of  previously  affected
* The results to be reported in this paper are based on a cooperative  study  with
Lieutenant-Colonel  Charles  F.  Craig,  Medical  Corps,  U.  S. Army,  Director  of
the Laboratories  of the Army  Medical  School at Washington,  D. C.  It was  at
his  invitation that  this  work  was  begun  and  his keen interest  and  cooperation
made the study  possible.  Our thanks  are  also due  to the  members of his  staff
for most cordial and helpful assistance.
lOlitsky, P.  K., and Gates, F. L., J. Exp. Med., 1922, xxxv, 1.
2  Olitsky, P.  K., and Gates, F. L., J. Exp. Med.,  1922,  xxxv, 553.
3  Olitsky, P. K., and  Gates, F. L., J. Exp. Med.,  1922,  xxxvi,  685.
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rabbits,  in  doses pathogenic  for  normal animals.  Consequently,  in  the absence
of the damage which  B. pneumosintes induces in  unprotected  rabbit lungs,  these
vaccinated animals, after intratracheal injection with living B. pneumosintes, were
found  to be as a rule as resistant  as normal rabbits  to secondary  infection  with
pneumococcus,  streptococcus,  and B.  pfeijJeri under conditions  in  which  control
rabbits  were affected.  This  resistance  to infection  with ordinary  bacteria  was
maintained  also  during  the  period  immediately  following  a  single  injection  of
killed B.  pneumosintes five  times  the  usual  dose.  Thus  no  evidence  indicative
of  a  so  called  "negative  phase"  was  obtained.  Attention  is  directed  to  these
observations  because  of the association  of pulmonary  injury due to B. pneumo-
sintes with secondary  invasions  of  the damaged  lung by ordinary bacteria  which
parallels  so  nearly  the  relation  of  epidemic  influenza  to  secondary  pneumonic
infections in human  beings.
The  conclusion  stated was  that  "the  mildness  of  the  local  reactions  and  the
absence of general signs [in rabbits], following vaccination with Bacterium pneumo-
sintes, indicate  that similar injections  would  be well tolerated  in man."
In  view  of  the specific  protection  afforded  to rabbits  and  the ab-
sence  of  any  defect  in resistance  to  other  infections  as  a result  of
subcutaneous  vaccination  with  Bacterium pneumosintes, and  having
in mind the possible relationship  of epidemic influenza  to this micro-
organism,  a group of fourteen volunteers at the Army Medical  School
in Washington,  D. C., indicated their desire  to submit to the vaccina-
tion.  Nine  of  these  persons  had  never  had  epidemic  influenza.
Four had suffered  from the disease in 1918-19  and one in 1920.
These  volunteers  were  accordingly  given  three  graded  doses  of
heat-killed  cultures  of  Bacterium pneumosintes,  and  three  of  them
were given a fourth and larger  dose.  Blood specimens were obtained
before  and  after  vaccination  for  comparison  in  agglutination  tests.
Leucocyte  counts  were  also made  before,  and  daily for 3 days  after
each  injection,  and  the  local  and  general  reactions  following  each
dose were  noted.  The  small  size of  the group  was compensated  for
by the opportunity  to study the reactions  of each person in detail.
Preparation  of  Vaccine.
Our observations  indicated  the cultural and  antigenic  identity of  our strains
of  B.  pneumosintes, whether  derived  from  the  epidemic  waves  of  1918-19,  or
1920,  or  the recurrence  of  1922.  As  in the  instance  of the  vaccination  carried
4 Olitsky, P.  K., and Gates,  F. L., J. Exp. Med.,  1921,  xxxiv, 1.PETER  K.  OLITSKY  AND  FREDERICK  L.  GATES
out  in  the  rabbit  series,  we again  used  two  strains  in preparing  the  vaccine;
Strain  17,  from  the  nasopharyngeal  secretions  of a patient attacked  during  the
1918-19  epidemic,  and  Strain  34,  from  similar  secretions  obtained  during  the
1922  recurrence  of  influenza.  The  organisms  were  grown  in  large  quantities
in B. coll broth,5 prepared by adding  10 cc.  of a  24 hour broth culture of B. coli
to 1 liter of 1 per cent dextrose broth in a  Florence  flask and incubating  for  1 to
2 hours at 370C.,  or until the faintest visible  haze of growth appeared in  the clear
medium.  The  medium  was  then  heated  in  an Arnold  steamer  at  1000C.  for
30 minutes  under a  petrolatum  seal.  The  rapidly cooled broth,  now  sterile  and
anaerobic, was then seeded  with 2 cc. of the respective cultures of B. pneumosintes
grown in  Smith-Noguchi  medium.  After 3 to 5 days incubation,  heavy growths
were  obtained,  which  were  centrifuged,  washed  with  distilled  water,  and  re-
suspended in salt solution  as  a stock vaccine.  This  was  heated for 30  minutes
at  55-56°C.  and  standardized  by  an  opacity  method. 6 It  was  then  preserved
with 0.35 per cent triple distilled cresol and before use it was diluted to correspond
to a  staphylococcus  equivalent s of 2,000 million  and 3,000 million organisms per
cubic  centimeter.  After  aerobic  and  anaerobic  tests  for  viability  and  con-
tamination  proved negative,  the vaccine  was ready  for use.
Dosage.
Of  the  fourteen  volunteers  (ten  enlisted  men  and  four  officers)
thirteen  were  studied  as  described  below.  The remaining  man  re-
ceived  only the first two injections and could not be further observed.
A first  dose of 0.5  cc.  (1,000  million)  and  second  and  third  doses  of
1 cc.  (2,000  million) were  given.  Three  men  received  in  addition  a
fourth dose of  1 cc.  (3,000 million).  All of  the  doses  were  estimated
on the staphylococcus  scale.
The interval  between  the  first  and  second  injections  was  5  days
(exceptions:  4  days  in  one instance  and  8  in another)  and  between
the second  and  third injections  8  days  (exceptions:  7  days  in  three
instances and 4 days in a fourth).  In the three instances in which a
fourth dose was given, the interval between the third and fourth doses
was  10  days.
Reactions.
The first  dose of  1,000  million was well  tolerated.  In  only  three
instances  were  slight  constitutional  disturbances  such  as  headache,
mild  depression,  and  generalized  pains  experienced.  One  of  these
6 Olitsky,  P. K., and Gates,  F. L., J. Exp.  Med.,  1922,  xxxv, 813.
6 Gates, F. L., J. Exp. Med.,  1920,  xxxi,  105.
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men had  slight chilly  sensations  also.  The  symptoms  were  transi-
tory,  beginning  8  to  10  hours  after injection  and  lasting  for  a  few
hours  only.  All  of the  men had  some  tenderness  and  redness  over
an area  6 to  8  cm. in diameter  at the site  of injection,  without any
induration,  as a rule.  The local  reaction subsided  after 2 to 3 days.
No one was  even temporarily  incapacitated.
The  second  dose  of  2,000 million  was  equally  well borne.  Again
three  men  reported  the  general  symptoms  already  mentioned.  In
no instance did the temperature  rise above 99°F.  (37.2°C.).  Locally,
the effects of the reaction were somewhat more severe,  for induration
was evident  in areas 1 to 2 cm.  in diameter, which persisted  for  7 to
8 days.  None of the volunteers was kept from their daily routine.
No  constitutional  reactions  were  experienced  after the  third  dose
of 2,000 million.  The  local reactions were  similar to those following
the second  injection.
Finally,  in  view  of  the  mildness  of  the  reaction  with  the  doses
employed,  three persons submitted  to a fourth  dose  of  3,000 million,
given  10 days after the third inoculation.  The vaccine was injected
at  10  a.m.  At  8  p.m.  on the same  day  one  of  the  three  showed  a
temperature  of 990F. (37.2°C.),  but did not complain of any constitu-
tional  symptoms.  The  next  morning  the  temperature  was  normal.
However, there developed locally over an area 4 cm. in  diameter some
redness and induration attended with little or no tenderness.  During
the night the second man complained  of headache,  dryness of mouth
and lips, and some weakness.  The temperature was 99.4°F. (37.4 0C.).
By the next morning the temperature  was normal  and the constitu-
tional symptoms had disappeared.  The site of inoculation was tender
and  slightly  indurated  and  the  area  of  redness  covered  one-half  of
the posterior aspect  of  the upper  arm.  At 8.30 p.m. on the day of
inoculation the third person showed a temperature  of 100°F.  (37.8°C.)
and complained of dryness of the throat and slight pains in the muscles
of the legs.  By morning these symptoms had disappeared.  Locally
there  was  a  red  and  tender  area,  without  induration,  measuring  5
to  6  cm.  None  of  these  three  was  incapacitated  for duty  by  the
injection.  It  may  therefore be  stated that the injection  of  doses  of
killed Bacterium pneumosintes, equivalent  in amount to  3,000 million
staphylococci,  induces a milder reaction than that usually noted with
the second  or third dose  of triple  typhoid  vaccine.PETER  K.  OLITSKY  AND  REDERICK  L.  GATES
Effect  on  the  Blood  Count.
Leucocyte  counts were made on nine of the vaccinated men before,
and for  3  consecutive  days  after each injection.  In each instance a
rise in the  total  counts occurred,  which carried  the average  for  the
nine men to 124,  134, and  143 per cent of its normal value,  as shown
in Text-fig.  1.  In the chart the mononuclear  cells have been plotted
separately  to show  the differences  in their behavior,  especially  after
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TEXT-FIG.  1.  The effect  of subcutaneous  injections of heat-killed  suspensions
of B. pneumosintes on  the total and mononuclear  leucocyte  count.
the  first and  second  injections,  as  compared  with the  total  counts.
It  is interesting  to note that,  after the first and second injections,  in
spite of a rise in the total count which was part of the general reaction,
the mononuclear cells suffered an absolute decrease.  On the following
day  their  recovery  was  disproportionately  rapid  and  restored  the
normal  ratio  between  them  and  the  total  count.  The  leucocytosis
was transient  and the totals fell again between the 2nd and 3rd days
following injection.
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At the time  of  the third injection  the average  count  of the  mono-
nuclear cells was  found  to be high, and it rose  to a  new level during
the following  24  hours,  to fall  again  somewhat  the next day.  Two
sets of  final figures  are  given  in the  chart.  On that day  the counts
of two of the men  were recorded as 16,600 cells per c. mm., 4,000  cells
more than  any  other count  on that day and  respectively  8,600  and
3,800  cells  more  than  the  corresponding  figures  for  the day  before.
We  have no  explanation  for  these  sudden and  unexpected  changes,
for  they  were  not  accompanied  by  any  observable  clinical  signs.
With  these  two  exceptions  the  counts  throughout  the  series  were
fairly uniform, so that the average figures give a reliable picture of the
general  effects.  If these exceptional  figures  are  included,  they  shift
the average  counts to the points marked 1 on the chart.  If excluded,
the averages  of  the remaining  counts  fall at the points  marked  2.
Production of  Agglutinins.
The  doses  of  vaccine  given  to  the  rabbits  were  relatively  much
larger  than those  administered to the men.  They were followed by
the  appearance  of  specific  agglutinins  in  the  blood  of  the  rabbits?3
Agglutinins  have  also  been  demonstrated  in the serum  of  seventeen
of nineteen persons who had recently  recovered from epidemic  influ-
enza. 7 In  the  present  case  of  the  vaccinated  men  tests for  agglu-
tinins were carried out by the method already  described.7
An examination  prior to vaccination  of the blood serum of the men
was made  in dilutions  of 1: 2  to 1: 10.  No  agglutinins  against either
of  the  strains  of  Bacterium pneumosintes used  in  the  vaccine  were
found present.  A  second specimen  was obtained from twelve  of the
vaccinated  men  on  the  10th  day,  and  from  the  other  man  on  the
11th day after the third injection.  The results  of  the  agglutination
tests with these  sera are  recorded  in Table  I.
An examination  of the table shows that the blood of eleven  of  the
thirteen  vaccinated  persons  contained  agglutinins  against  the  two
strains  of Bacterium pneumosintes in serum  dilutions  of  1:4 to  1:40.
In the serum  of two,  no agglutinins were  detected.  It  is, of  course,
possible that agglutinins might have been found in the blood of these
7 Olitsky,  P. K., and Gates,  F. L.,  J. Exp. Med.,  1923,  xxxvii, 303.PETER  K.  OLITSKY  AND  FREDERICK  L.  GATES  477
men had more specimens  been studied.  Such variations in antibody
response  are, of course, known  for other organisms.8'9
In view  of  the mildness  of  the reactions  in this preliminary  series,
and the harmlessness  of  the injections,  Lieutenant-Colonel  Craig has
offered  the pneumosintes vaccine  to  a much larger  group  of  men at
TABLE  I.
Agglutination of Serum after Vaccination.
Case No.
1
2
3
4
5
6
7t
8
9
10
11
12
13
No  serum.
Strain 17.'
1:4
+++
+++
++
++
++
++
+
++
1:10
++
++
++
++
++
+
1:20
+
1:40
Serum
buffer.
1:4
0
Strain  34.'
1:4
++.
+++
+++
++
+
+++
+
++
+
+
1:10
++
++
+
+
±±
+
_3
1:20
+
+
++
1:40
+
* Strain  17  was obtained  from the  1918-19  wave,  and Strain  34 from  the 1922
wave  of the influenza  epidemic.
t  The specimen from  this person was obtained  11  days after the last  injection.
Specimens from the remainder were collected  10 days after the vaccination  series.
+++  indicates  complete  agglutination  with  clear  supernatant  fluid;  ++,
almost complete agglutination with slightly clouded supernatant fluid;  +, distinct
agglutination  with  clouded  supernatant  fluid;  -,  no  agglutination  or  serum
flocculation;  and  0, no test made.
Fort Meyer, who have availed themselves  of the opportunity.  Should
there  be  a  recurrence  of  epidemic  influenza  in the  near  future,  the
efficacy  of the vaccination may receive a practical test.
8  Maverick,  A.,  J.  Am.  Med.  Assn.,  1912,  lviii,  1672.  Trowbridge,  E.  H.,
Finkle,  B. A.,  and Barnard,  E. M., J. Am.  Med. Assn.,  1915,  xiv, 728.
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SUMMARY.
Thirteen  volunteers  were  injected  subcutaneously  with  a  vaccine
prepared  from  two strains of  Bacterium pneumosintes.  Three  doses
were  given  corresponding,  by  opacity  tests,  to  1,000,  2,000,  and
2,000 million staphylococci.  The intervals between the several injec-
tions  were  5 and  8  days.  Local  reactions  of  mild  and  transitory
character  only  were  noted.  Constitutional  reactions,  also mild  and
transitory,  consisting  of headache,  depression,  and  generalized  mus-
cular pains,  were infrequently  observed.  None of  the men was pre-
vented by the vaccine  from pursuing  his ordinary duties.  The vac-
cinations induce a transitory leucocytosis and lead to the appearance
of  specific  agglutinins  in the  blood serum.